Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Weiss: Protection by Neutralizing Antibodies |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Antibody Characterization |
| Species: | Non-organism study |
| Stage: | Assays complete |
| Study Start Date: | 2010-01-18 |
| Study Made Public: | 2010-08-05 |
Title
Neutralizing studies on an East London cohort infected with diverse clades of HIV-1
Description
CAVD 311 is an immunogenicity study of broadly neutralizing antibodies in an East London cohort infected with diverse clades of HIV-1.
Sign in to see full information about this study and to download study data.
Products
No Products used in studyIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.